Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas

Hiroshi Shirakawa, Eiji Kikuchi, Shuji Mikami, Shigeru Fukamachi, Yasumasa Miyazaki, Nobuyuki Tanaka, Akira Miyajima, Mototsugu Oya

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This report presents three cases of urinary upper tract carcinomas producing granulocyte colony-stimulating factor (G-CSF), with high blood leukocyte counts and poor prognoses. Case 1 was a 73-year-old man who underwent nephroureterectomy for left renal pelvic carcinoma. Pathologically, urothelial carcinoma (UC), high-grade, was observed, and immunohistochemical analysis showed positive staining for G-CSF. Progressive disease (PD) was observed despite administration of systemic chemotherapy for disease relapse, and the patient died 4.5 months after the operation. Case 2 was a 74-year-old man who had left renal pelvic carcinoma with para-aortic lymph-node metastases. The serum G-CSF was elevated (169 pg/ml). The patient refused any aggressive treatment, and died 2.3 months after his first visit to the hospital. Case 3 was a 75-year-old woman who had left renal pelvic carcinoma with adrenal metastasis. Biopsy confirmed the diagnosis as UC with squamous differentiation, and the serum G-CSF was elevated (138 pg/ml). Systemic chemotherapy was administered. However, the patient showed PD, and died 6.9 months after her first visit to the hospital. Effective treatment strategies are warranted for carcinomas producing G-CSF. Elucidation of the actions of G-CSF on both the carcinoma cells and the tumor microenvironment may contribute to the development of useful strategies.

Original languageEnglish
Pages (from-to)136-141
Number of pages6
JournalScandinavian Journal of Urology and Nephrology
Volume46
Issue number2
DOIs
Publication statusPublished - 2012 Apr

Fingerprint

Granulocyte Colony-Stimulating Factor
Urinary Tract
Carcinoma
Kidney
Neoplasm Metastasis
Cellular Microenvironment
Drug Therapy
Tumor Microenvironment
Serum
Leukocyte Count
Squamous Cell Carcinoma
Lymph Nodes
Staining and Labeling
Biopsy
Recurrence
Therapeutics

Keywords

  • Granulocyte colony-stimulating factor
  • Renal pelvic carcinoma
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas. / Shirakawa, Hiroshi; Kikuchi, Eiji; Mikami, Shuji; Fukamachi, Shigeru; Miyazaki, Yasumasa; Tanaka, Nobuyuki; Miyajima, Akira; Oya, Mototsugu.

In: Scandinavian Journal of Urology and Nephrology, Vol. 46, No. 2, 04.2012, p. 136-141.

Research output: Contribution to journalArticle

Shirakawa, Hiroshi ; Kikuchi, Eiji ; Mikami, Shuji ; Fukamachi, Shigeru ; Miyazaki, Yasumasa ; Tanaka, Nobuyuki ; Miyajima, Akira ; Oya, Mototsugu. / Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas. In: Scandinavian Journal of Urology and Nephrology. 2012 ; Vol. 46, No. 2. pp. 136-141.
@article{1ddc94c5dfc441c19778dcb52f74ab45,
title = "Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas",
abstract = "This report presents three cases of urinary upper tract carcinomas producing granulocyte colony-stimulating factor (G-CSF), with high blood leukocyte counts and poor prognoses. Case 1 was a 73-year-old man who underwent nephroureterectomy for left renal pelvic carcinoma. Pathologically, urothelial carcinoma (UC), high-grade, was observed, and immunohistochemical analysis showed positive staining for G-CSF. Progressive disease (PD) was observed despite administration of systemic chemotherapy for disease relapse, and the patient died 4.5 months after the operation. Case 2 was a 74-year-old man who had left renal pelvic carcinoma with para-aortic lymph-node metastases. The serum G-CSF was elevated (169 pg/ml). The patient refused any aggressive treatment, and died 2.3 months after his first visit to the hospital. Case 3 was a 75-year-old woman who had left renal pelvic carcinoma with adrenal metastasis. Biopsy confirmed the diagnosis as UC with squamous differentiation, and the serum G-CSF was elevated (138 pg/ml). Systemic chemotherapy was administered. However, the patient showed PD, and died 6.9 months after her first visit to the hospital. Effective treatment strategies are warranted for carcinomas producing G-CSF. Elucidation of the actions of G-CSF on both the carcinoma cells and the tumor microenvironment may contribute to the development of useful strategies.",
keywords = "Granulocyte colony-stimulating factor, Renal pelvic carcinoma, Urothelial carcinoma",
author = "Hiroshi Shirakawa and Eiji Kikuchi and Shuji Mikami and Shigeru Fukamachi and Yasumasa Miyazaki and Nobuyuki Tanaka and Akira Miyajima and Mototsugu Oya",
year = "2012",
month = "4",
doi = "10.3109/00365599.2011.644863",
language = "English",
volume = "46",
pages = "136--141",
journal = "Scandinavian Journal of Urology",
issn = "2168-1805",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas

AU - Shirakawa, Hiroshi

AU - Kikuchi, Eiji

AU - Mikami, Shuji

AU - Fukamachi, Shigeru

AU - Miyazaki, Yasumasa

AU - Tanaka, Nobuyuki

AU - Miyajima, Akira

AU - Oya, Mototsugu

PY - 2012/4

Y1 - 2012/4

N2 - This report presents three cases of urinary upper tract carcinomas producing granulocyte colony-stimulating factor (G-CSF), with high blood leukocyte counts and poor prognoses. Case 1 was a 73-year-old man who underwent nephroureterectomy for left renal pelvic carcinoma. Pathologically, urothelial carcinoma (UC), high-grade, was observed, and immunohistochemical analysis showed positive staining for G-CSF. Progressive disease (PD) was observed despite administration of systemic chemotherapy for disease relapse, and the patient died 4.5 months after the operation. Case 2 was a 74-year-old man who had left renal pelvic carcinoma with para-aortic lymph-node metastases. The serum G-CSF was elevated (169 pg/ml). The patient refused any aggressive treatment, and died 2.3 months after his first visit to the hospital. Case 3 was a 75-year-old woman who had left renal pelvic carcinoma with adrenal metastasis. Biopsy confirmed the diagnosis as UC with squamous differentiation, and the serum G-CSF was elevated (138 pg/ml). Systemic chemotherapy was administered. However, the patient showed PD, and died 6.9 months after her first visit to the hospital. Effective treatment strategies are warranted for carcinomas producing G-CSF. Elucidation of the actions of G-CSF on both the carcinoma cells and the tumor microenvironment may contribute to the development of useful strategies.

AB - This report presents three cases of urinary upper tract carcinomas producing granulocyte colony-stimulating factor (G-CSF), with high blood leukocyte counts and poor prognoses. Case 1 was a 73-year-old man who underwent nephroureterectomy for left renal pelvic carcinoma. Pathologically, urothelial carcinoma (UC), high-grade, was observed, and immunohistochemical analysis showed positive staining for G-CSF. Progressive disease (PD) was observed despite administration of systemic chemotherapy for disease relapse, and the patient died 4.5 months after the operation. Case 2 was a 74-year-old man who had left renal pelvic carcinoma with para-aortic lymph-node metastases. The serum G-CSF was elevated (169 pg/ml). The patient refused any aggressive treatment, and died 2.3 months after his first visit to the hospital. Case 3 was a 75-year-old woman who had left renal pelvic carcinoma with adrenal metastasis. Biopsy confirmed the diagnosis as UC with squamous differentiation, and the serum G-CSF was elevated (138 pg/ml). Systemic chemotherapy was administered. However, the patient showed PD, and died 6.9 months after her first visit to the hospital. Effective treatment strategies are warranted for carcinomas producing G-CSF. Elucidation of the actions of G-CSF on both the carcinoma cells and the tumor microenvironment may contribute to the development of useful strategies.

KW - Granulocyte colony-stimulating factor

KW - Renal pelvic carcinoma

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84858392484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858392484&partnerID=8YFLogxK

U2 - 10.3109/00365599.2011.644863

DO - 10.3109/00365599.2011.644863

M3 - Article

VL - 46

SP - 136

EP - 141

JO - Scandinavian Journal of Urology

JF - Scandinavian Journal of Urology

SN - 2168-1805

IS - 2

ER -